{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:12:57Z","timestamp":1791216777795,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41409-020-0897-2","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T09:05:09Z","timestamp":1588064709000},"page":"1906-1917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT)"],"prefix":"10.1038","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9203-7446","authenticated-orcid":false,"given":"Ghada","family":"ElGohary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"El Fakih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis","family":"de Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4744-5109","authenticated-orcid":false,"given":"Antonio","family":"Risitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Gluckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"H\u00f6chsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Pierri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantijn","family":"Halkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazzaa","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0974-1249","authenticated-orcid":false,"given":"Josu","family":"De la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alahmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Osman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bacigalupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"897_CR1","first-page":"301","volume":"13","author":"P Ehrlich","year":"1888","unstructured":"Ehrlich P. Ueber einem Fall von An\u00e4mie mit Bemerkungen \u00fcber regenerative Ver\u00e4nderungen des Knochenmarks. Charit\u00e9-Ann. 1888;13:301\u20139.","journal-title":"Charit\u00e9-Ann"},{"key":"897_CR2","first-page":"637","volume-title":"Osler\u2019s modern medicine","author":"Cabot RC Diseases of the Blood.","year":"1908","unstructured":"Cabot RC Diseases of the Blood. Osler\u2019s modern medicine. Philadelphia: Lea & Febiger; 1908. p. 637."},{"key":"897_CR3","doi-asserted-by":"crossref","unstructured":"Vaht K, G\u00f6ransson M, Carlson K, Isaksson C, Lenhoff S, Sandstedt A, et al. Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000\u20132011. Haematologica. 2017;102:1683\u201390.","DOI":"10.3324\/haematol.2017.169862"},{"key":"897_CR4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00277-018-3486-3","volume":"98","author":"SS Li","year":"2019","unstructured":"Li SS, Hsu YT, Chang C, Lee SC, Yen CC, Cheng CN, et al. Incidence and treatment outcome of aplastic anemia in Taiwan-real-world data from single-institute experience and a nationwide population-based database. Ann Hematol. 2019;98:29\u201339.","journal-title":"Ann Hematol"},{"key":"897_CR5","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","volume":"376","author":"DM Townsley","year":"2017","unstructured":"Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, et al. Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med. 2017;376:1540\u201350.","journal-title":"N Engl J Med"},{"key":"897_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1200931","volume":"367","author":"MJ Olnes","year":"2012","unstructured":"Olnes MJ, Scheinberg P, Calvo KR, Desmond R, Tang Y, Dumitriu B, et al. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med. 2012;367:11\u20139.","journal-title":"N Engl J Med"},{"key":"897_CR7","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood-2013-10-534743","volume":"123","author":"R Desmond","year":"2014","unstructured":"Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, et al. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood. 2014;123:1818\u201325.","journal-title":"Blood"},{"key":"897_CR8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/ehm.11.11","volume":"4","author":"AE Dezern","year":"2011","unstructured":"Dezern AE, Brodsky RA. Clinical management of aplastic anemia. Expert Rev Hematol. 2011;4:221\u201330.","journal-title":"Expert Rev Hematol"},{"key":"897_CR9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","volume":"120","author":"P Scheinberg","year":"2012","unstructured":"Scheinberg P, Young NS. How I treat acquired aplastic anemia. Blood. 2012;120:1185\u201396.","journal-title":"Blood"},{"key":"897_CR10","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood.V124.21.2498.2498","volume":"124","author":"MT Lupo-Stanghellini","year":"2014","unstructured":"Lupo-Stanghellini MT, Orsini A, Crucitti L, Crocchiolo R, Greco R, Forcina A, et al. Graft-versus-host disease after haploidentical stem cell transplantation in high risk haematological diseases: a 10-years evaluation at San Raffaele Scientific Institute. Blood. 2014;124:2498.","journal-title":"Blood"},{"key":"897_CR11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s15010-017-1016-1","volume":"45","author":"E Atilla","year":"2017","unstructured":"Atilla E, Atilla PA, Bozdag SC, Demirer T. A review of infectious complications after haploidentical hematopoietic stem cell transplantations. Infection. 2017;45:403\u201311.","journal-title":"Infection"},{"key":"897_CR12","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","volume":"125","author":"Y Wang","year":"2015","unstructured":"Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X, et al. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood. 2015;125:3956\u201362.","journal-title":"Blood"},{"key":"897_CR13","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1158\/1078-0432.CCR-15-2335","volume":"22","author":"Y Wang","year":"2016","unstructured":"Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X, et al. Haploidentical versus matched-sibling transplant in adults with Philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III randomized study. Clin Cancer Res. 2016;22:3467\u201376.","journal-title":"Clin Cancer Res"},{"key":"897_CR14","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/bloodadvances.2018021162","volume":"2","author":"GE Georges","year":"2018","unstructured":"Georges GE, Doney K, Storb R. Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment. Blood Adv. 2018;2:2020\u20138.","journal-title":"Blood Adv"},{"key":"897_CR15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.seminhematol.2019.03.004","volume":"56","author":"A Bacigalupo","year":"2019","unstructured":"Bacigalupo A, Giammarco S. Haploidentical donor transplants for severe aplastic anemia. Semin Hematol. 2019;56:190\u20133.","journal-title":"Semin Hematol"},{"key":"897_CR16","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.bbmt.2014.06.028","volume":"20","author":"J Clay","year":"2014","unstructured":"Clay J, Kulasekararaj AG, Potter V, Grimaldi F, McLornan D, Raj K, et al. Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia. Biol Blood Marrow Transplant. 2014;20:1711\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"key":"897_CR17","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbmt.2013.01.023","volume":"19","author":"HJ Im","year":"2013","unstructured":"Im HJ, Koh KN, Choi ES, Jang S, Kwon SW, Park CJ, et al. Excellent outcome of haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia. Biol Blood Marrow Transplant. 2013;19:754\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"897_CR18","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/bmt.2012.79","volume":"47","author":"LP Xu","year":"2012","unstructured":"Xu LP, Liu KY, Liu DH, Han W, Chen H, Chen YH, et al. A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia. Bone Marrow Transplant. 2012;47:1507\u201312.","journal-title":"Bone Marrow Transplant"},{"key":"897_CR19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/bmt.2015.20","volume":"50","author":"I Esteves","year":"2015","unstructured":"Esteves I, Bonfim C, Pasquini R, Funke V, Pereira NF, Rocha V, et al. Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study. Bone Marrow Transplant. 2015;50:685\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"897_CR20","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"897_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","volume":"48","author":"BM Camitta","year":"1976","unstructured":"Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48:63\u201370.","journal-title":"Blood"},{"key":"897_CR22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5966\/sctm.2012-0115","volume":"2","author":"AD Sung","year":"2013","unstructured":"Sung AD, Chao NJ. Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment. Stem Cells Transl Med. 2013;2:25\u201332.","journal-title":"Stem Cells Transl Med"},{"key":"897_CR23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21:389\u2013401.e1.","journal-title":"Biol Blood Marrow Transplant"},{"key":"897_CR24","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol. 1988;6:1562\u20138.","journal-title":"J Clin Oncol"},{"key":"897_CR25","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628\u201333.","journal-title":"Biol Blood Marrow Transplant"},{"key":"897_CR26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"897_CR27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/aje\/kwq099","volume":"172","author":"Y Xu","year":"2010","unstructured":"Xu Y, Cheung YB, Lam KF, Tan SH, Milligan P. A simple approach to the estimation of incidence rate difference. Am J Epidemiol. 2010;172:334\u201343.","journal-title":"Am J Epidemiol"},{"key":"897_CR28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/ejh.13060","volume":"100","author":"C Yue","year":"2018","unstructured":"Yue C, Ding Y, Gao Y, Li L, Pang Y, Liu Z, et al. Cotransplantation of haploidentical hematopoietic stem cells and allogeneic bone marrow-derived mesenchymal stromal cells as a first-line treatment in very severe aplastic anemia patients with refractory infections. Eur J Haematol. 2018;100:624\u20139.","journal-title":"Eur J Haematol"},{"key":"897_CR29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbmt.2016.12.628","volume":"23","author":"AE DeZern","year":"2017","unstructured":"DeZern AE, Zahurak M, Symons H, Cooke K, Jones RJ, Brodsky RA. Alternative donor transplantation with high-dose post-transplantation cyclophosphamide for refractory severe aplastic anemia. Biol Blood Marrow Transplant. 2017;23:498\u2013504.","journal-title":"Biol Blood Marrow Transplant"},{"key":"897_CR30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbmt.2019.01.010","volume":"25","author":"H Kim","year":"2019","unstructured":"Kim H, Im HJ, Koh KN, Kang SH, Yoo JW, Choi ES, et al. Comparable outcome with a faster engraftment of optimized haploidentical hematopoietic stem cell transplantation compared with transplantations from other donor types in pediatric acquired aplastic anemia. Biol Blood Marrow Transplant. 2019;25:965\u201374.","journal-title":"Biol Blood Marrow Transplant"},{"key":"897_CR31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","volume":"10","author":"L-P Xu","year":"2017","unstructured":"Xu L-P, Jin S, Wang S-Q, Xia L-H, Bai H, Gao S-J, et al. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol. 2017;10:25.","journal-title":"J Hematol Oncol"},{"key":"897_CR32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbmt.2019.01.017","volume":"25","author":"S Yang","year":"2019","unstructured":"Yang S, Yuan X, Ma R, Jiang L, Guo J, Zang Y, et al. Comparison of outcomes of frontline immunosuppressive therapy and frontline haploidentical hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched sibling donor. Biol Blood Marrow Transplant. 2019;25:975\u201380.","journal-title":"Biol Blood Marrow Transplant"},{"key":"897_CR33","doi-asserted-by":"crossref","first-page":"83817","DOI":"10.18632\/oncotarget.19745","volume":"8","author":"W Yamei","year":"2017","unstructured":"Yamei W, Rongmu L, Yongbin C, Yingjian S, Xiaohong L, Xiaomei Z, et al. Improved outcome of haploidentical transplantation in severe aplastic anemia using reduced-intensity fludarabine-based conditioning. Oncotarget. 2017;8:83817\u201330.","journal-title":"Oncotarget"},{"key":"897_CR34","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.bbmt.2018.05.015","volume":"24","author":"Y Lu","year":"2018","unstructured":"Lu Y, Sun RJ, Zhao YL, Xiong M, Cao XY, Zhang JP, et al. Unmanipulated haploidentical hematopoietic stem cell transplantation achieved outcomes comparable with matched unrelated donor transplantation in young acquired severe aplastic anemia. Biol Blood Marrow Transplant. 2018;24:1881\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"key":"897_CR35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/bmt.2017.237","volume":"53","author":"LP Xu","year":"2018","unstructured":"Xu LP, Xu ZL, Wang FR, Mo XD, Han TT, Han W, et al. Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia. Bone Marrow Transplant. 2018;53:188\u201392.","journal-title":"Bone Marrow Transplant"},{"key":"897_CR36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/bmt.2013.224","volume":"49","author":"L Gao","year":"2014","unstructured":"Gao L, Li Y, Zhang Y, Chen X, Gao L, Zhang C, et al. Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy. Bone Marrow Transplant. 2014;49:519\u201324.","journal-title":"Bone Marrow Transplant"},{"key":"897_CR37","doi-asserted-by":"crossref","first-page":"e89666","DOI":"10.1371\/journal.pone.0089666","volume":"9","author":"XH Li","year":"2014","unstructured":"Li XH, Gao CJ, Da WM, Cao YB, Wang ZH, Xu LX, et al. Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia. PLoS ONE. 2014;9:e89666.","journal-title":"PLoS ONE"},{"key":"897_CR38","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/bjh.14110","volume":"174","author":"H Zhu","year":"2016","unstructured":"Zhu H, Luo RM, Luan Z, Lee V, Zhu YP, Luo CJ, et al. Unmanipulated haploidentical haematopoietic stem cell transplantation for children with severe aplastic anaemia. Br J Haematol. 2016;174:799\u2013805.","journal-title":"Br J Haematol"},{"key":"897_CR39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00277-018-3523-2","volume":"98","author":"Z Wang","year":"2018","unstructured":"Wang Z, Yu H, Cao F, Liu Z, Liu Z, Feng W, et al. Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children. Ann Hematol. 2018;98:473\u20139.","journal-title":"Ann Hematol"},{"key":"897_CR40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjh.14225","volume":"175","author":"LP Xu","year":"2016","unstructured":"Xu LP, Wang SQ, Wu DP, Wang JM, Gao SJ, Jiang M, et al. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study. Br J Haematol. 2016;175:265\u201374.","journal-title":"Br J Haematol"},{"key":"897_CR41","doi-asserted-by":"crossref","first-page":"3905907","DOI":"10.1155\/2016\/3905907","volume":"2016","author":"K Parmesar","year":"2016","unstructured":"Parmesar K, Raj K. Haploidentical stem cell transplantation in adult haematological malignancies. Adv Hematol. 2016;2016:3905907.","journal-title":"Adv Hematol"},{"key":"897_CR42","doi-asserted-by":"crossref","first-page":"e005039","DOI":"10.1136\/bmjopen-2014-005039","volume":"4","author":"F Peinemann","year":"2014","unstructured":"Peinemann F, Labeit AM. Stem cell transplantation of matched sibling donors compared with immunosuppressive therapy for acquired severe aplastic anaemia: a Cochrane systematic review. BMJ Open. 2014;4:e005039.","journal-title":"BMJ Open"},{"key":"897_CR43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","volume":"147","author":"JC Marsh","year":"2009","unstructured":"Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43\u201370.","journal-title":"Br J Haematol"},{"key":"897_CR44","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.bbmt.2010.04.005","volume":"16","author":"D Sangiolo","year":"2010","unstructured":"Sangiolo D, Storb R, Deeg HJ, Flowers ME, Martin PJ, Sandmaier BM, et al. Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age. Biol Blood Marrow Transplant. 2010;16:1411\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"897_CR45","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3324\/haematol.2009.007583","volume":"94","author":"F Peinemann","year":"2009","unstructured":"Peinemann F, Grouven U, Kroger N, Pittler M, Zschorlich B, Lange S. Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review. Haematologica. 2009;94:1732\u201342.","journal-title":"Haematologica"},{"key":"897_CR46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbmt.2017.09.018","volume":"24","author":"AE Hammerstrom","year":"2018","unstructured":"Hammerstrom AE, Lombardi LR, Pingali SR, Rondon G, Chen J, Milton DR, et al. Prevention of cytomegalovirus reactivation in haploidentical stem cell transplantation. Biol Blood Marrow Transplant. 2018;24:353\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"897_CR47","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.4049\/jimmunol.1500117","volume":"194","author":"AS Henden","year":"2015","unstructured":"Henden AS, Hill GR. Cytokines in graft-versus-host disease. J Immunol. 2015;194:4604\u201312.","journal-title":"J Immunol"},{"key":"897_CR48","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","volume":"124","author":"MF Martelli","year":"2014","unstructured":"Martelli MF, Di Ianni M, Ruggeri L, Falzetti F, Carotti A, Terenzi A, et al. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. Blood. 2014;124:638\u201344.","journal-title":"Blood"},{"key":"897_CR49","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jcyt.2013.05.014","volume":"15","author":"M Schumm","year":"2013","unstructured":"Schumm M, Lang P, Bethge W, Faul C, Feuchtinger T, Pfeiffer M, et al. Depletion of T-cell receptor alpha\/beta and CD19 positive cells from apheresis products with the CliniMACS device. Cytotherapy. 2013;15:1253\u20138.","journal-title":"Cytotherapy"},{"key":"897_CR50","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbmt.2014.01.032","volume":"20","author":"M Bleakley","year":"2014","unstructured":"Bleakley M, Heimfeld S, Jones LA, Turtle C, Krause D, Riddell SR, et al. Engineering human peripheral blood stem cell grafts that are depleted of na\u00efve T cells and retain functional pathogen-specific memory T cells. Biol Blood Marrow Transplant. 2014;20:705\u201316.","journal-title":"Biol Blood Marrow Transplant"},{"key":"897_CR51","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2017-05-785659","volume":"130","author":"SO Ciurea","year":"2017","unstructured":"Ciurea SO, Schafer JR, Bassett R, Denman CJ, Cao K, Willis D, et al. Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation. Blood. 2017;130:1857\u201368.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-020-0897-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-020-0897-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-020-0897-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:18:10Z","timestamp":1684603090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-020-0897-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1038\/s41409-020-0897-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737848018.793577871","asserted-by":"object"}]},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"11 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}